Cargando…
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
Cancer progression generates a chronic inflammatory state that dramatically influences hematopoiesis, originating different subsets of immune cells that can exert pro- or anti-tumor roles. Commitment towards one of these opposing phenotypes is driven by inflammatory and metabolic stimuli derived fro...
Autores principales: | Bleve, Augusto, Durante, Barbara, Sica, Antonio, Consonni, Francesca Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461616/ https://www.ncbi.nlm.nih.gov/pubmed/32823961 http://dx.doi.org/10.3390/ijms21165845 |
Ejemplares similares
-
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
por: Bleve, Augusto, et al.
Publicado: (2022) -
Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
por: Bleve, Augusto, et al.
Publicado: (2022) -
Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
por: Consonni, Francesca Maria, et al.
Publicado: (2019) -
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression
por: Sica, Antonio, et al.
Publicado: (2019) -
Immunometabolic interference between cancer and COVID-19
por: Consonni, Francesca Maria, et al.
Publicado: (2023)